PRNB
Principia Biopharma Inc.
No insider bought or sold Principia Biopharma Inc. in the last 12 months
PRNB over the last year
Prices for PRNB aren't in yet.
PRNB after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
35 insider filings since 2018, newest first
Roy C. Hardiman · Chief Business Officer
Dolca Thomas · Chief Medical Officer
Christopher Y Chai · CFO
David M Goldstein · Chief Scientific Officer
Dolca Thomas · Chief Medical Officer
Alan Colowick · Director
Martin Babler · President and CEO
Stefani Wolff · Chief Development Officer
Stefani Wolff · Chief Development Officer
Stefani Wolff · Chief Development Officer
Roy C. Hardiman · Chief Business Officer
Christopher Y Chai · CFO
David M Goldstein · Chief Scientific Officer
Alan Colowick · Director
Roy C. Hardiman · Chief Business Officer
Martin Babler · President and CEO
Christopher Y Chai · CFO
David Goldstein · Chief Scientific Officer
Dolca Thomas · Chief Medical Officer
Martin Babler · President and CEO
Roy C. Hardiman · Chief Business Officer
David Goldstein · Chief Scientific Officer
Daniel J. Becker · Director
Glaxosmithkline Plc · Former 10% Owner
Simeon George · Director
Daniel J. Becker · Director
New Leaf Ventures Ii, L.P. · 10% owner
Orbimed Advisors LLC · 10% owner
Orbimed Advisors LLC · 10% owner
Simeon George · Director and 10% owner
Glaxosmithkline Plc · 10% owner
Sofinnova Venture Partners Viii, L.P. · 10% owner
Daniel J. Becker · Director and 10% owner
New Leaf Ventures Ii, L.P. · 10% owner
Srinivas Akkaraju · Director
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.